JP2016501225A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016501225A5 JP2016501225A5 JP2015545197A JP2015545197A JP2016501225A5 JP 2016501225 A5 JP2016501225 A5 JP 2016501225A5 JP 2015545197 A JP2015545197 A JP 2015545197A JP 2015545197 A JP2015545197 A JP 2015545197A JP 2016501225 A5 JP2016501225 A5 JP 2016501225A5
- Authority
- JP
- Japan
- Prior art keywords
- bryoid
- formulation
- disease
- formulation according
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261730761P | 2012-11-28 | 2012-11-28 | |
| US61/730,761 | 2012-11-28 | ||
| PCT/US2013/072076 WO2014085494A1 (en) | 2012-11-28 | 2013-11-26 | Combination therapeutics and methods for the treatment of neurodegenerative and other diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016501225A JP2016501225A (ja) | 2016-01-18 |
| JP2016501225A5 true JP2016501225A5 (enExample) | 2019-03-22 |
| JP6579956B2 JP6579956B2 (ja) | 2019-09-25 |
Family
ID=50828429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015545197A Expired - Fee Related JP6579956B2 (ja) | 2012-11-28 | 2013-11-26 | 神経変性疾患および他の疾患の治療のための併用治療薬および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10828276B2 (enExample) |
| EP (1) | EP2925314B1 (enExample) |
| JP (1) | JP6579956B2 (enExample) |
| CN (1) | CN105228614A (enExample) |
| HK (1) | HK1218882A1 (enExample) |
| WO (1) | WO2014085494A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9994585B2 (en) | 2007-12-31 | 2018-06-12 | Aphios Corporation | Transplantation therapies |
| US9034347B2 (en) | 2011-12-19 | 2015-05-19 | Arphios Corporation | Drug delivery system and method for the treatment of neuro-degenerative disease |
| JP6579956B2 (ja) | 2012-11-28 | 2019-09-25 | アフィオス コーポレーション | 神経変性疾患および他の疾患の治療のための併用治療薬および方法 |
| WO2026024784A1 (en) * | 2024-07-22 | 2026-01-29 | Mastery Biotech Co., Ltd. | Composition and method for preventing or treating neurodegenerative diseases |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4560774A (en) * | 1982-11-17 | 1985-12-24 | Arizona State University | Macrocyclic lactones |
| US4611066A (en) * | 1984-08-10 | 1986-09-09 | Arizona State University | Bryostatins 4 to 8 |
| US5440055A (en) | 1993-03-12 | 1995-08-08 | Aphios Corporation | Method and apparatus for extracting taxol from source materials |
| US5854064A (en) | 1996-07-31 | 1998-12-29 | Aphios Corporation | Methods for fractionation of biologically-derived materials |
| GB9325395D0 (en) | 1993-12-11 | 1994-02-16 | Ciba Geigy Ag | Compositions |
| IE75744B1 (en) | 1995-04-03 | 1997-09-24 | Elan Corp Plc | Controlled release biodegradable micro- and nanospheres containing cyclosporin |
| EP0888458A4 (en) | 1996-02-20 | 2004-05-06 | Sloan Kettering Institutefor C | COMBINATION OF PKC INHIBITORS AND THERAPEUTIC AGENTS FOR TREATING CANCER |
| GB9620390D0 (en) | 1996-09-30 | 1996-11-13 | Eisai London Res Lab Ltd | Substances and their uses |
| US6221153B1 (en) | 1998-06-09 | 2001-04-24 | Trevor Percival Castor | Method for producing large crystals of complex molecules |
| US6228843B1 (en) | 1999-04-23 | 2001-05-08 | University Technology Corporation | Method of using PKC inhibiting compounds to treat vascular disease |
| CA2393026A1 (en) | 1999-11-30 | 2001-06-07 | Paul A. Wender | Bryostatin analogues, synthetic methods and uses |
| WO2002028387A1 (en) * | 2000-10-03 | 2002-04-11 | Oncopharmaceutical, Inc. | Inhibitors of angiogenesis and tumor growth for local and systemic administration |
| US20080004332A1 (en) | 2002-03-07 | 2008-01-03 | Alkon Daniel L | Methods for alzheimer's disease treatment and cognitive enhancement |
| US6825229B2 (en) | 2002-03-07 | 2004-11-30 | Blanchette Rockefeller Neurosciences Institute | Methods for Alzheimer's Disease treatment and cognitive enhancement |
| WO2003086369A2 (en) * | 2002-04-05 | 2003-10-23 | Valorisation-Recherche, Societe En Commandite | Stealthy polymeric biodegradable nanospheres and uses thereof |
| CA2490494A1 (en) * | 2002-07-02 | 2004-01-15 | Blanchette Rockefeller Neurosciences Institute | Pkc activation as a means for enhancing sapp.alpha. secretion and improving cognition using bryostatin type compounds |
| JP4890759B2 (ja) | 2002-07-02 | 2012-03-07 | ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート | ｓＡＰＰα分泌を増強させる及びブリオスタチン型化合物を用いて認知を改善させるための手段としてのＰＫＣ活性化 |
| US8088605B2 (en) * | 2002-12-04 | 2012-01-03 | Technologies Biolactics Inc. | Exopolysaccharides delivery system for active molecules |
| AU2005240078A1 (en) | 2004-04-30 | 2005-11-17 | Allergan, Inc. | Retinoid-containing sustained release intraocular drug delivery systems and related methods of manufacturing |
| US7871358B2 (en) * | 2005-10-14 | 2011-01-18 | Gary Graham | Height adjustable shuttle treatment table/exercise device method and apparatus |
| WO2007114881A1 (en) | 2006-01-24 | 2007-10-11 | Nexbio, Inc. | Technology for preparation of macromolecular microspheres |
| CN101848726A (zh) | 2007-02-09 | 2010-09-29 | 布朗歇特洛克菲勒神经科学研究所 | 苔藓抑素、苔藓抑素类似物和其它相关物质对头部创伤引起的记忆缺陷和脑损伤的疗效 |
| US8071119B2 (en) * | 2007-05-14 | 2011-12-06 | Sustained Nano Systems Llc | Controlled release implantable dispensing device and method |
| US8497385B2 (en) * | 2007-08-31 | 2013-07-30 | The Board Of Trustees Of The Leland Stanford Junior University | Bryostatin analogues, synthetic methods and uses |
| US9994585B2 (en) | 2007-12-31 | 2018-06-12 | Aphios Corporation | Transplantation therapies |
| US20100168219A1 (en) | 2008-12-31 | 2010-07-01 | Jonathan Steven Alexander | Chronic inflammation and transplantation |
| US20120309818A1 (en) | 2007-12-31 | 2012-12-06 | Jonathan Steven Alexander | Chronic inflammation and transplantation |
| WO2009129361A2 (en) | 2008-04-16 | 2009-10-22 | University Of Utah Research Foundation | Macrocyclic compounds and methods of making and using thereof |
| WO2009132050A2 (en) | 2008-04-21 | 2009-10-29 | Otonomy, Inc. | Auris formulations for treating otic diseases and conditions |
| US20110129450A1 (en) * | 2008-08-01 | 2011-06-02 | Orly Lazarov | Method of promoting neurogenesis by modulating secretase activities |
| US20100166806A1 (en) * | 2008-12-29 | 2010-07-01 | Aphios Corporation | Combination therapy comprising the use of protein kinase C modulators and Histone Deacetylase inhibitors for treating HIV-1 latency |
| CN102459180B (zh) * | 2009-06-09 | 2014-05-14 | 江苏迈度药物研发有限公司 | 作为激酶抑制剂的脲衍生物 |
| WO2013071282A1 (en) * | 2011-11-13 | 2013-05-16 | Blanchette Rockefeller Neurosciences Institute | Pkc activators and combinations thereof |
| US9034347B2 (en) | 2011-12-19 | 2015-05-19 | Arphios Corporation | Drug delivery system and method for the treatment of neuro-degenerative disease |
| CN105008342B (zh) | 2012-11-27 | 2018-10-19 | 阿菲欧斯公司 | 苔藓素组合物、其制备方法和用途 |
| JP6579956B2 (ja) | 2012-11-28 | 2019-09-25 | アフィオス コーポレーション | 神経変性疾患および他の疾患の治療のための併用治療薬および方法 |
-
2013
- 2013-11-26 JP JP2015545197A patent/JP6579956B2/ja not_active Expired - Fee Related
- 2013-11-26 US US14/646,817 patent/US10828276B2/en active Active
- 2013-11-26 EP EP13858873.6A patent/EP2925314B1/en active Active
- 2013-11-26 CN CN201380070968.5A patent/CN105228614A/zh active Pending
- 2013-11-26 HK HK16106972.1A patent/HK1218882A1/zh unknown
- 2013-11-26 WO PCT/US2013/072076 patent/WO2014085494A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vergaro et al. | Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells | |
| Akbari et al. | Antiviral polymers: a review | |
| Pham et al. | Strategies for the design of orally bioavailable antileishmanial treatments | |
| JP2013067645A5 (enExample) | ||
| JP2012524724A5 (enExample) | ||
| WO2013132457A3 (en) | Nanocrystalline solid dispersion compositions and process of preparation thereof | |
| Dua et al. | Application of chitosan and its derivatives in nanocarrier based pulmonary drug delivery systems | |
| JP2016535777A5 (enExample) | ||
| IL295418B1 (en) | Beta-d-2'-deoxy-2' alpha-fluoro-2'-bata-c-modified-2-different-n6-purine modified nucleotides for the treatment of hepatitis c virus | |
| RU2013106172A (ru) | Композиция для снятия усталости, состав и их применение | |
| JP2018520189A5 (enExample) | ||
| JP2013511507A5 (enExample) | ||
| JP2013542205A5 (enExample) | ||
| CN102499911A (zh) | 一种茶皂苷纳米囊及其制备方法和应用 | |
| TW202245806A (zh) | Ａｔ—５２７半硫酸鹽之有利型式 | |
| JP2015531749A5 (enExample) | ||
| CY1124635T1 (el) | Ξηρες φαρμακευτικες συνθεσεις που περιεχουν νανοσωματιδια ενεργου παραγοντα δεσμευμενα σε σωματιδια φορεα | |
| WO2009084041A3 (en) | Pharmaceutical compositions of dexibuprofen | |
| JP2014062109A5 (enExample) | ||
| RU2015113031A (ru) | Использование 3-n-бутил изоиндолин кетонов при приготовлении лекарственных средств для профилактики и лечения церебрального инфаркта | |
| RU2012110454A (ru) | Способ получения микрокапсул лекарственных препаратов группы цефалоспоринов в интерфероне | |
| Tran et al. | Recent strategic developments in the use of superdisintegrants for drug delivery | |
| HRP20220701T1 (hr) | Spojeni benzazepini za liječenje touretteova sindroma | |
| WO2014085494A8 (en) | Combination therapeutics and methods for the treatment of neurodegenerative and other diseases | |
| JP2022508236A5 (enExample) |